Table 6.

Ventral hippocampus: significant post hoc comparisons summary

Mouse strain	Inactivation	Statistical test	Test delay	Significant post hoc comparisons (context: treatment)	Mean 1	Mean 2	N1	N2	t	df	p	*	Figure
C57BL/6	Systemic	Two-way ANOVA	1 d	Training: hM4D versus novel: hM4D	58.9	5.36	6	7	6.5	21	<0.001	***	4F
				Training: hM4D versus novel: EGFP	58.9	7.35	6	6	6	21	<0.001	***
				Training: EGFP versus novel: hM4D	53.7	5.36	6	7	5.8	21	<0.001	***
				Training: EGFP versus novel: EGFP	53.7	7.35	6	6	5.4	21	<0.001	***
			28 d	Training: hM4D versus novel: hM4D	70.2	7.1	5	5	7.3	16	<0.001	***
				Training: hM4D versus novel: EGFP	70.2	46	5	5	2.8	16	0.012	*
				Training: EGFP versus novel: hM4D	60.7	7.1	5	5	6.2	16	<0.001	***
				Novel: hM4D versus novel: EGFP	7.1	46	5	5	4.5	16	<0.001	***
	BLA terminals		1 d	Training: hM4D versus novel: hM4D	51.6	4.57	6	5	5.2	20	<0.001	***	5F
				Training: hM4D versus novel: EGFP	51.6	7.16	6	6	5.2	20	<0.001	***
				Training: EGFP versus novel: hM4D	61.6	4.57	7	5	6.5	20	<0.001	***
				Training: EGFP versus novel: EGFP	61.6	7.16	7	6	6.6	20	<0.001	***
			28 d	Training: hM4D versus novel: hM4D	58.7	7.9	7	6	3.9	24	<0.001	***
				Training: EGFP versus novel: hM4D	50	7.9	7	6	3.2	24	0.003	**
				Novel: hM4D versus novel: EGFP	7.9	36.1	6	8	2.2	24	0.035	*
C57BL/6 × 129S1vmJ		Repeated-measures two-way ANOVA	1 d	hM4D: training versus novel	62.8	40.6	7	7	2.6	13	0.023	*	6E
				EGFP: training versus novel	71.3	42.2	8	8	3.6	13	0.003	**
			28 d	hM4D: training versus novel	80.8	14.5	5	5	8.7	9	<0.001	***
				EGFP: training versus novel	76	49.2	6	6	3.8	9	0.008	**
				Novel: hM4D versus novel: EGFP	14.5	49.2	5	6	4.5	18	<0.001	***